Denmark’s economy extended gains in the third quarter as drugmakers continued to grow their output while domestic demand also ...

Eli Lilly shares are down 11% since president-elect Donald Trump nominated Robert F. Kennedy, Jr. to be Secretary of Health ...

European mega-caps trail US 'Magnificent 7' amid lack of artificial intelligence gains, while also facing China's slowdown ...

The move intensifies the competition with Eli Lilly, which secured approval for its weight loss drug in China in July but has ...

Novo Resources has bolstered its bank balance with the sale of its remaining 20 per cent interest in the Quartz Hill ...

Catalent is vulnerable to facility closures whether from natural disasters or manufacturing issues, and a warning letter from the FDA or other regulatory agency can result in manufacturing delays or ...

A groundbreaking Harvard study reveals that semaglutide could benefit more people in the U.S. than ever imagined.

Drugmakers are likewise reaching out to other employers with the message that treating obesity will ultimately save them money.

Prior to the election, Biden was eager to talk about the existential threat that the president-elect posed to American democracy and the nightmarish future he said would follow if Trump ever returned ...

Novo Nordisk’s blockbuster weight-loss drug Wegovy is now available for use in China, the company confirmed to AFP on Tuesday, as the Asian nation battles ...

The efforts by Eli Lilly and Novo Nordisk could be a game-changer for sales, which some analysts say could exceed $100 ...